CLOs on the Move


 
KoKo, LLC is a global respiratory information systems software developer and medical device manufacturing company. The exclusive provider of Iris™, the world`s first Integrated Respiratory Information System; and KoKo® pulmonary function testing, diagnostic spirometry, and respiratory home monitoring devices. Our expert, scalable software solutions and sophisticated data collection products empower healthcare providers to advance respiratory diagnostic processes and improve patient outcomes while meeting the demanding clinical and business objectives of thought leaders in respiratory care.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.kokopft.com
  • 1200 S Fordham Street Suite B
    Longmont, CO USA 80503
  • Phone: 720.640.4222

Executives

Name Title Contact Details

Similar Companies

Bioventus

Bioventus®Inc. (Nasdaq: BVS) develops Innovations for Active Healing and its mission is to make a difference by helping patients resume and enjoy active lives. The Company has products for pain treatment & joint preservation, restorative therapies and bone graft substitutes. Established in 2012, Bioventus is headquartered in Durham, NC. The company has more than 800 employees worldwide and its international headquarters is in Hoofddorp, The Netherlands. Bioventus also has offices in Memphis, TN, Valencia, CA, Hod Hasharon, Israel and Mississauga, Ontario, Canada. Bioventus works with patients, payers and health care providers throughout the world.

Global Medical

Global Medical is a Elkridge, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

FlexMedical Disposables

FlexMedical Disposables is a Irving, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

GandJ Medical Supply

G&J Medical Supply is a Asheville, NC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Median Technologies

Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. As The Imaging Phenomics Company®, Median provides insights into novel therapies and treatment strategies. Our unique solutions, MediScan® for lesion management in patient care, Lesion Management Solution (LMS) for lesion detection, measurement and reporting in clinical trials, and our imaging phenotyping system iBiopsy®, together with our global team of experts, are advancing the development of new drugs and diagnostic tools to monitor disease and assess response to therapy. Median Technologies supports biopharmaceutical sponsors and healthcare professionals around the world in bringing new and targeted treatments to patients in need with an eye on reducing overall costs. This is how we are helping to create a healthier world. Founded in 2002, based in Sophia-Antipolis, France, with a US subsidiary in Boston, Median has received the label “Innovative company” by the BPI and is listed on Euronext Paris` Alternext market (ISIN: FR0011049824, ticker: ALMDT). The company is eligible for the PEA-PME SME equity savings plan setup and has received the label Pass French Tech Promotion 2016-2017.